Under the assumption of similar general legal environments, the following analysis suggests that a strategy of confidential secrecy in R&D is less significant for Japanese enterprises. Founded upon this difference the amount of patent induced information disclosure effects for Japan is not as...

The decisive statutory provision of the EU for patent protection of genetic engineering inventions is the so-called directive on biotechnological patents (DBP). Its objective is the encouragement of research and development in the genetic engineering sector. The following exposition shows that...

Under the assumption of similar general legal environments, the following analysis suggests that a strategy of confidential secrecy in R&D is less significant for Japanese enterprises. Founded upon this difference the amount of patent induced information disclosure effects for Japan is not as...

The decisive statutory provision of the EU for patent protection of genetic engineering inventions is the so-called directive on biotechnological patents (DBP). Its objective is the encouragement of research and development in the genetic engineering sector. The following exposition shows that...